Amendment: Fulminant Myocarditis Linked to Sjögren’s Syndrome Manifesting as Cardiogenic Shock Necessitating VA-ECMO: A Case Study
-
By
-
Thanh Hoa Tran
-
Quoc Thang Le
-
Thao My Doan Ai
-
Sinh Hien Nguyen
-
September 25, 2026
Clinical Scorecard: Amendment: Fulminant Myocarditis Linked to Sjögren’s Syndrome Manifesting as Cardiogenic Shock Necessitating VA-ECMO: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Fulminant Myocarditis |
| Key Mechanisms | Linked to Sjögren’s Syndrome |
| Target Population | Patients with Sjögren’s Syndrome |
| Care Setting | Cardiovascular care |
Key Highlights
- Case study of fulminant myocarditis
- Associated with Sjögren’s Syndrome
- Manifested as cardiogenic shock
- Necessitated VA-ECMO support
- Correction of authorship noted
Guideline-Based Recommendations
Diagnosis
- Consider myocarditis in patients with Sjögren’s Syndrome presenting with cardiac symptoms
Management
- Utilize VA-ECMO for severe cardiogenic shock
Monitoring & Follow-up
- Continuous cardiac monitoring in critical care settings
Risks
- Potential for rapid deterioration in myocarditis cases
Patient & Prescribing Data
Patients with Sjögren’s Syndrome experiencing cardiac complications
VA-ECMO may be required in severe cases
Clinical Best Practices
- Early recognition of myocarditis symptoms
- Multidisciplinary approach for management
- Regular follow-up for cardiac function in Sjögren’s patients
Related Resources & Content
